Related references
Note: Only part of the references are listed.Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients
Antonella Nai et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Iron chelation may harm patients with COVID-19
Michael D. Garrick et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Reply: Iron chelation may harm patients with COVID-19
Anis Abobaker
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Association between iron status and the risk of adverse outcomes in COVID-19
Yanling Lv et al.
CLINICAL NUTRITION (2021)
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19
Sema Yagci et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Iron metabolism in infections: Focus on COVID-19
Domenico Girelli et al.
SEMINARS IN HEMATOLOGY (2021)
Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19
Vipul Chakurkar et al.
SCIENTIFIC REPORTS (2021)
A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research
Taulant Muka et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases
Kai Kappert et al.
BIOMARKERS (2020)
Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
Anis Abobaker
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
Carlo Perricone et al.
IMMUNOLOGIC RESEARCH (2020)
Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study
Giuliano Bolondi et al.
WORLD JOURNAL OF EMERGENCY SURGERY (2020)
Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
Marvin Edeas et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Serum Iron Level as a Potential Predictor of Coronavirus Disease 2019 Severity and Mortality: A Retrospective Study
Kang Zhao et al.
Open Forum Infectious Diseases (2020)
COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein
Sepehr Ehsani
BIOLOGY DIRECT (2020)
Hypoferremia is Associated With Increased Hospitalization and Oxygen Demand in COVID-19 Patients
Theresa Hippchen et al.
HEMASPHERE (2020)
Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study
Thomas Sonnweber et al.
RESPIRATORY RESEARCH (2020)
Increased Serum Levels of Hepcidin and Ferritin Are Associated with Severity of COVID-19
Cuixing Zhou et al.
MEDICAL SCIENCE MONITOR (2020)
Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19
Akshay Shah et al.
CRITICAL CARE (2020)
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis
Ian Huang et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)
Depriving Iron Supply to the Virus Represents a Promising Adjuvant Therapeutic Against Viral Survival
Wei Liu et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2020)
The development of the concept of ferroptosis
Tal Hirschhorn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease
Matthew Sheetz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
The opposing effects of acute inflammation and iron deficiency anemia on serum hepcidin and iron absorption in young women
Nicole U. Stoffel et al.
HAEMATOLOGICA (2019)
Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients
Sigismond Lasocki et al.
CRITICAL CARE (2018)
Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin
Sharraya Aschemeyer et al.
BLOOD (2018)
Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease
Raed Daher et al.
PRESSE MEDICALE (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Iron homeostasis in host defence and inflammation
Tomas Ganz et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Hepcidin and iron homeostasis
Tomas Ganz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia
Barbra J. Sasu et al.
BLOOD (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Share Paper
